Terms: = Prostate cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
4 results:
1. Active surveillance for low-risk prostate cancer.
Klotz L
Curr Opin Urol; 2017 May; 27(3):225-230. PubMed ID: 28267056
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine: Changing the Treatment Paradigms.
Goodwin CR; Abu-Bonsrah N; Rhines LD; Verlaan JJ; Bilsky MH; Laufer I; Boriani S; Sciubba DM; Bettegowda C
Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20():S218-S223. PubMed ID: 27488299
[TBL] [Abstract] [Full Text] [Related]
3. MR-based prognostic nomogram for prostate cancer after radical prostatectomy.
Zhang YD; Wu CJ; Bao ML; Li H; Wang XN; Liu XS; Shi HB
J Magn Reson Imaging; 2017 Feb; 45(2):586-596. PubMed ID: 27654116
[TBL] [Abstract] [Full Text] [Related]
4. Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and prostate cancer.
Ligthart ST; Coumans FA; Bidard FC; Simkens LH; Punt CJ; de Groot MR; Attard G; de Bono JS; Pierga JY; Terstappen LW
PLoS One; 2013; 8(6):e67148. PubMed ID: 23826219
[TBL] [Abstract] [Full Text] [Related]